Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin: clinical applications.

P Foa1

  • 1Istituto di Scienze Mediche, Padiglione Granelli, Milano, Italia.

Acta Haematologica
|January 1, 1991
PubMed
Summary

Erythropoietin (Epo) research has advanced significantly, covering its purification, gene isolation, and expression. This review details Epo

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA).

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2011
Same author

Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC).

Oncology reports·2011
Same author

Fluorescence in situ hybridization (FISH) for evaluating residual disease in Philadelphia chromosome-positive chronic myeloid leukemia during interferon alpha therapy.

Oncology reports·2011

Area of Science:

  • Biochemistry and Molecular Biology
  • Hematology
  • Clinical Medicine

Background:

  • Recent advancements in understanding erythropoietin (Epo)
  • Purification and amino acid sequencing of Epo
  • Isolation and expression of the Epo gene in mammalian cell lines

Purpose of the Study:

  • To review the crucial biological features of erythropoietin (Epo)
  • To critically examine clinical trial results involving Epo in humans

Main Methods:

  • Literature review of recent scientific publications
  • Analysis of data from human clinical trials

Main Results:

  • Summary of key biological characteristics of Epo
  • Overview of outcomes from Epo-related clinical studies

Conclusions:

  • Erythropoietin (Epo) has undergone significant research advancements
  • Clinical applications and outcomes of Epo therapy are critically evaluated